Non-adherence in non-inferiority trials: pitfalls and recommendations

Non-adherence in non-inferiority trials: pitfalls and recommendations

Non-adherence in non-inferiority trials can affect treatment effect estimates and often increases the chance of claiming non-inferiority under the standard intention-to-treat analysis. This article discusses the implications of different patterns of non-adherence in non-inferiority trials and offers...

Bibliografske podrobnosti
Main Authors:	Mo, Y, Lim, C, Watson, JA, Nicholas J White, Cooper, BS
Format:	Journal article
Jezik:	English
Izdano:	BMJ Publishing Group 2020

Podobne knjige/članki

Statistical considerations in the design and analysis of non-inferiority trials with binary endpoints in the presence of non-adherence: a simulation study
od: Mo, Y, et al.
Izdano: (2020)

Statistical considerations in the design and analysis of non-inferiority trials with binary endpoints in the presence of non-adherence: a simulation study [version 2; peer review: 2 approved]
od: Yin Mo, et al.
Izdano: (2020-04-01)

Non-inferiority and equivalence trials
od: Ranstam, J, et al.
Izdano: (2017)

Statistical methods for non-adherence in non-inferiority trials: useful and used? A systematic review
od: Matthew Dodd, et al.
Izdano: (2022-01-01)

Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance
od: Verdon Renaud, et al.
Izdano: (2006-09-01)

Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance: Response
od: van Leth Frank, et al.
Izdano: (2007-03-01)

Equivalence and non inferiority trials
od: D’Agostino Ralph B
Izdano: (2011-12-01)

Testing for non-inferior mortality: a systematic review of non-inferiority margin sizes and trial characteristics
od: Nick Daneman, et al.
Izdano: (2021-04-01)

Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
od: Quartagno, M, et al.
Izdano: (2020)

Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
od: Matteo Quartagno, et al.
Izdano: (2020-02-01)

The ethics of switch/simplify in antiretroviral trials: non-inferior or just inferior?
od: Andrew Carr, et al.
Izdano: (2012-01-01)

Design of phase II non-inferiority trials
od: Sin-Ho Jung
Izdano: (2017-09-01)

Regulatory scientific advice on non-inferiority drug trials.
od: Grace Wangge, et al.
Izdano: (2013-01-01)

Treating non-responders: pitfalls and implications for cancer immunotherapy trial design
od: Zhenzhen Xu, et al.
Izdano: (2020-03-01)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
od: Woodrow Charles J, et al.
Izdano: (2010-04-01)

Evaluating "superiority", "equivalence" and "non-inferiority" in clinical trials
od: Turan Fatma, et al.
Izdano: (2007-01-01)

Adherence and acceptability of multiple micronutrient supplementation during pregnancy: Study protocol for a cluster-randomized non-inferiority trial in Cambodia
od: Mai-Anh Hoang, et al.
Izdano: (2024-04-01)

Comparing Articaine brands: A randomized non-inferiority controlled trial
od: D. Arboleda-Toro, et al.
Izdano: (2021-06-01)

Reimagining Health Communication: A Non-Inferiority Randomized Controlled Trial of Crowdsourcing in China
od: W. Tang, et al.
Izdano: (2017-04-01)

Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes
od: Turner, RM, et al.
Izdano: (2023)

Non-Parametric Non-Inferiority Assessment in a Three-Arm Trial with Non-Ignorable Missing Data
od: Wei Li, et al.
Izdano: (2023-01-01)

Non-representativeness in corpora: perils, pitfalls and challenges
od: Thomas Egan
Izdano: (2019-06-01)

Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
od: Salvador Machlab, et al.
Izdano: (2024-03-01)

Non-inferiority and equivalence trials: Need for a standardized process
od: Suresh Keshav Bowalekar
Izdano: (2011-01-01)

Testing of Hypothesis in Equivalence and Non Inferiority Trials-A Concept
od: Atul Juneja, et al.
Izdano: (2016-04-01)

Understanding the null hypothesis (H0) in non-inferiority trials
od: Jihad Mallat
Izdano: (2017-05-01)

Non-inferiority clinical trials: importance and applications in health sciences
od: Heitor Marques HONÓRIO, et al.
Izdano: (2020-08-01)

Superiority, equivalence or non-inferiority?
od: Cipriani, A, et al.
Izdano: (2009)

Evidence-based sizing of non-inferiority trials using decision models
od: Iris Lansdorp-Vogelaar, et al.
Izdano: (2019-01-01)

A review of UK publicly funded non-inferiority trials: is the design more inferior than it should be?
od: Nikki Totton, et al.
Izdano: (2024-12-01)

Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial
od: Mo, Y, et al.
Izdano: (2024)

The trials and tribulations of conducting an m-health pilot randomized controlled trial to improve oral cancer therapy adherence: recommendations for future multisite, non-drug clinical trials
od: Lahiru Russell, et al.
Izdano: (2019-04-01)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
od: Awab, G, et al.
Izdano: (2010)

A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome
od: Adriana Albani, et al.
Izdano: (2019-10-01)

Who protects participants in non-inferiority trials when the outcome is death?
od: Walter Palmas
Izdano: (2018-01-01)

Response to: Understanding the null hypothesis (H0) in non-inferiority trials
od: Xiang Zhou, et al.
Izdano: (2017-08-01)

Editorial on hypothesis and objectives in clinical trials: superiority, equivalence and non-inferiority
od: Bolaños Ricardo, et al.
Izdano: (2009-03-01)

Non-inferiority versus equivalence clinical trials in assessing biological products
od: Valdair Ferreira Pinto

Diagnostic pitfalls of non-secretory myeloma: The biochemical perspective
od: Rashmi Rasi Datta, et al.
Izdano: (2024-02-01)

Levels and correlates of non-adherence to WHO recommended inter-birth intervals in Rufiji, Tanzania
od: Exavery Amon, et al.
Izdano: (2012-12-01)